I am curious as to which party approached which regarding this collaboration.
My initial feeling is that while I'm unclear about the benefits of the arrangement- I've got faith in PYC management. They wouldn't pursue/accept an arrangement that ostensibly cost 5.5m if they didn't see some significant strategic benefit.
Hopefully some more enlightened posters here with a better understanding of the AI implications can help educate me/us in what this all means.
Ann: AI Driven Drug Discovery Collaboration with Google Cloud, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.010(0.80%) |
Mkt cap ! $737.8M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.27 | $1.24 | $21.80K | 17.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1909 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 6135 | 3 |
View Market Depth
| Last trade - 13.03pm 30/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |